Cargando…

Drug Delivery Approaches for the Treatment of Cervical Cancer

Cervical cancer is a highly prevalent cancer that affects women around the world. With the availability of new technologies, researchers have increased their efforts to develop new drug delivery systems in cervical cancer chemotherapy. In this review, we summarized some of the recent research in sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ordikhani, Farideh, Erdem Arslan, Mustafa, Marcelo, Raymundo, Sahin, Ilyas, Grigsby, Perry, Schwarz, Julie K., Azab, Abdel Kareem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039442/ https://www.ncbi.nlm.nih.gov/pubmed/27447664 http://dx.doi.org/10.3390/pharmaceutics8030023

Ejemplares similares

Clathrin light chain‐conjugated drug delivery for cancer
por: Jung, Sungwook, et al.
Publicado: (2022)

The prognostic value of PET and PET/CT in cervical cancer
por: Grigsby, Perry W.
Publicado: (2008)

Activation of miR-9 by human papillomavirus in cervical cancer
por: Liu, Weijun, et al.
Publicado: (2014)

Selinexor Overcomes Hypoxia-Induced Drug Resistance in Multiple Myeloma
por: Muz, Barbara, et al.
Publicado: (2017)

Improve definition of titanium tandems in MR-guided high dose rate brachytherapy for cervical cancer using proton density weighted MRI
por: Hu, Yanle, et al.
Publicado: (2013)

Nanomedicine applications in orthopedic medicine: state of the art
por: Mazaheri, Mozhdeh, et al.
Publicado: (2015)

AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake
por: Rashmi, Ramachandran, et al.
Publicado: (2014)

Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome
por: Brooks, Frank J, et al.
Publicado: (2011)

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma
por: Alhallak, Kinan, et al.
Publicado: (2021)

Macrophages in Organ Transplantation
por: Ordikhani, Farideh, et al.
Publicado: (2020)

FDG uptake heterogeneity in FIGO IIb cervical carcinoma does not predict pelvic lymph node involvement
por: Brooks, Frank J, et al.
Publicado: (2013)

00003 Volumetric assessment of cervical cancer tumor volume during definitive chemoradiation and the risk of early distant metastasis
por: Pachigolla, Suvidya Lakshmi, et al.
Publicado: (2021)

HPV transcript expression affects cervical cancer response to chemoradiation
por: Ruiz, Fiona J., et al.
Publicado: (2021)

Vaginal drug delivery for the localised treatment of cervical cancer
por: Major, Ian, et al.
Publicado: (2017)

A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer
por: Lin, Alexander J., et al.
Publicado: (2018)

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
por: Muz, Barbara, et al.
Publicado: (2015)

Ectopic high endothelial venules in pancreatic ductal adenocarcinoma: A unique site for targeted delivery
por: Bahmani, Baharak, et al.
Publicado: (2018)

Spatial relationship of 2-deoxy-2-[(18)F]-fluoro-D-glucose positron emission tomography and magnetic resonance diffusion imaging metrics in cervical cancer
por: Floberg, John M., et al.
Publicado: (2018)

Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas
por: Ruiz, Fiona J., et al.
Publicado: (2021)

Molecularly Targeted Therapies in Multiple Myeloma
por: de la Puente, Pilar, et al.
Publicado: (2014)

Patterns of care and survival outcomes after treatment for uveal melanoma in the post-coms era (2004-2013): a surveillance, epidemiology, and end results analysis
por: Rao, Yuan James, et al.
Publicado: (2017)

Theoretical studies of phosphorene as a drug delivery nanocarrier for fluorouracil
por: Esfandiarpour, Razieh, et al.
Publicado: (2023)

Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins
por: Sahin, Erdem, et al.
Publicado: (2018)

Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer
por: Grigsby, Perry, et al.
Publicado: (2017)

E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma
por: Maksimos, Mina, et al.
Publicado: (2023)

Possible role of nanocarriers in drug delivery against cervical cancer
por: Gupta, Swati, et al.
Publicado: (2017)

High Cervical Intrathecal Targeted Drug Delivery: A Case Report of Refractory Oropharyngeal Cancer Pain
por: Moman, Rajat N., et al.
Publicado: (2019)

Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib
por: Muz, Barbara, et al.
Publicado: (2015)

Biological Insights into Myeloma and Other B Cell Malignancies
por: Fulciniti, Mariateresa, et al.
Publicado: (2016)

SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation
por: Wang, Songyan, et al.
Publicado: (2022)

A Novel Approach to Teaching the Cervical Exam: A Versatile, Low-Cost Simulation for Labor and Delivery Learners
por: Perry, Jamie D, et al.
Publicado: (2021)

Spotlight on ixazomib: potential in the treatment of multiple myeloma
por: Muz, Barbara, et al.
Publicado: (2016)

Nanotechnology Approaches for Ocular Drug Delivery
por: Xu, Qingguo, et al.
Publicado: (2013)

Drug delivery approaches for breast cancer
por: Singh, Santosh Kumar, et al.
Publicado: (2017)

Bio-Targets and Drug Delivery Approaches
por: Kaushik, Meetu
Publicado: (2017)

Open stone surgery: a still-in-use approach for complex stone burden
por: Çakici, Özer Ural, et al.
Publicado: (2017)

Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: Treatment technique and outcomes
por: Rao, Yuan James, et al.
Publicado: (2017)

Controlled Drug Delivery by Polylactide Stereocomplex Micelle for Cervical Cancer Chemotherapy
por: Niu, Kai, et al.
Publicado: (2018)

Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer
por: Markovina, Stephanie, et al.
Publicado: (2018)

Intrathecal Drug Delivery Systems (IDDS): The Implantable Systems Performance Registry (ISPR)
por: Konrad, Peter E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_32g90kspi0jkdllno8qdvp1jta